BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11113626)

  • 1. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
    Rizzo WB; Heinz E; Simon M; Craft DA
    Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
    Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
    FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.
    Rizzo WB
    Biochim Biophys Acta; 2014 Mar; 1841(3):377-89. PubMed ID: 24036493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmalogens and fatty alcohols in rhizomelic chondrodysplasia punctata and Sjögren-Larsson syndrome.
    Malheiro AR; da Silva TF; Brites P
    J Inherit Metab Dis; 2015 Jan; 38(1):111-21. PubMed ID: 25432520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.
    James PF; Zoeller RA
    J Biol Chem; 1997 Sep; 272(38):23532-9. PubMed ID: 9295289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-O-Alkylglycerol accumulation reveals abnormal ether glycerolipid metabolism in Sjögren-Larsson syndrome.
    S'aulis D; Khoury EA; Zabel M; Rizzo WB
    Mol Genet Metab; 2020; 131(1-2):253-258. PubMed ID: 32800643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
    Rizzo WB
    Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren-Larsson syndrome: A biochemical rationale for using aldehyde-reactive therapeutic agents.
    Rizzo WB; S'aulis D; Dorwart E; Bailey Z
    Mol Genet Metab Rep; 2022 Mar; 30():100839. PubMed ID: 35242571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjogren-Larsson syndrome associated hypermelanosis.
    Xu YC; Hou JQ; Zhu WJ; Li P
    J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying fatty aldehyde metabolism in living cells with pyrene-labeled compounds.
    Keller MA; Watschinger K; Lange K; Golderer G; Werner-Felmayer G; Hermetter A; Wanders RJ; Werner ER
    J Lipid Res; 2012 Jul; 53(7):1410-6. PubMed ID: 22508945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome.
    Rizzo WB; Lin Z; Carney G
    Chem Biol Interact; 2001 Jan; 130-132(1-3):297-307. PubMed ID: 11306053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of fatty aldehyde dehydrogenase in the breakdown of phytol to phytanic acid.
    van den Brink DM; van Miert JN; Dacremont G; Rontani JF; Jansen GA; Wanders RJ
    Mol Genet Metab; 2004 May; 82(1):33-7. PubMed ID: 15110319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
    van den Brink DM; van Miert JM; Wanders RJ
    J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of recombinant human fatty aldehyde dehydrogenase: implications for Sjögren-Larsson syndrome.
    Lloyd MD; Boardman KD; Smith A; van den Brink DM; Wanders RJ; Threadgill MD
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):584-90. PubMed ID: 18035827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
    Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
    Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Skin Barrier Function Due to Reduced ω-
    Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
    Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.